[HTML][HTML] microRNA-33 deficiency in macrophages enhances autophagy, improves mitochondrial homeostasis, and protects against lung fibrosis

F Ahangari, NL Price, S Malik, M Chioccioli… - JCI insight, 2023 - ncbi.nlm.nih.gov
Idiopathic pulmonary fibrosis (IPF) is a progressive and ultimately fatal disease. Recent
findings have shown a marked metabolic reprogramming associated with changes in …

[HTML][HTML] MicroRNAs in cardiovascular disease: from pathogenesis to prevention and treatment

D Quiat, EN Olson - The Journal of clinical investigation, 2013 - Am Soc Clin Investig
The management of cardiovascular risk through lifestyle modification and pharmacotherapy
is paramount to the prevention of cardiovascular disease. Epidemiological studies have …

microRNA-33 regulates macrophage autophagy in atherosclerosis

M Ouimet, H Ediriweera, MS Afonso… - … and Vascular Biology, 2017 - Am Heart Assoc
Objective—Defective autophagy in macrophages leads to pathological processes that
contribute to atherosclerosis, including impaired cholesterol metabolism and defective …

[HTML][HTML] Mitochondrial CPT1A: Insights into structure, function, and basis for drug development

K Liang - Frontiers in pharmacology, 2023 - frontiersin.org
Carnitine Palmitoyl-Transferase1A (CPT1A) is the rate-limiting enzyme in the fatty acid β-
oxidation, and its deficiency or abnormal regulation can result in diseases like metabolic …

MicroRNAs in metabolic disease

C Fernández-Hernando, CM Ramírez… - … , and vascular biology, 2013 - Am Heart Assoc
Alterations in the metabolic control of lipid and glucose homeostasis predispose an
individual to develop cardiometabolic diseases, such as type 2-diabetes mellitus and …

Role of microRNAs in diabetes and its cardiovascular complications

S Shantikumar, A Caporali… - Cardiovascular …, 2012 - academic.oup.com
Diabetes is the most common metabolic disorder and is recognized as one of the most
important health threats of our time. MicroRNAs (miRNAs) are a novel group of non-coding …

[HTML][HTML] SIRT6 in aging, metabolism, inflammation and cardiovascular diseases

Z Guo, P Li, J Ge, H Li - Aging and disease, 2022 - ncbi.nlm.nih.gov
As an important NAD+-dependent enzyme, SIRT6 has received significant attention since its
discovery. In view of observations that SIRT6-deficient animals exhibit genomic instability …

Circulating adipocyte‐derived exosomal MicroRNAs associated with decreased insulin resistance after gastric bypass

MJ Hubal, EP Nadler, SC Ferrante, MD Barberio… - …, 2017 - Wiley Online Library
Objective Exosomes from obese adipose contain dysregulated microRNAs linked to insulin
signaling, as compared with lean controls, providing a direct connection between adiposity …

[HTML][HTML] Metformin elicits anticancer effects through the sequential modulation of DICER and c-MYC

G Blandino, M Valerio, M Cioce, F Mori… - Nature …, 2012 - nature.com
Diabetic patients treated with metformin have a reduced incidence of cancer and cancer-
related mortality. Here we show that metformin affects engraftment and growth of breast …

Towards decoding the coupled decision-making of metabolism and epithelial-to-mesenchymal transition in cancer

D Jia, JH Park, H Kaur, KH Jung, S Yang… - British Journal of …, 2021 - nature.com
Cancer cells have the plasticity to adjust their metabolic phenotypes for survival and
metastasis. A developmental programme known as epithelial-to-mesenchymal transition …